Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Trelagliptin Succinate Monotherapy for Type 2 Diabetes
NCT03940183 is registered in ClinicalTrials.gov with CSPC ZhongQi Pharmaceutical Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Trelagliptin Succinate Monotherapy for Type 2 Diabetes
- Lead sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 8, 2019
- Completion date
- December 28, 2020
- Enrollment
- 254 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.